Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Inflow-vascular space occupancy (iVASO) reproducibility in the hippocampus and cortex at different blood water nulling times.

Rane S, Talati P, Donahue MJ, Heckers S.

Magn Reson Med. 2016 Jun;75(6):2379-87. doi: 10.1002/mrm.25836. Epub 2015 Jul 20.

2.

Lack of parvalbumin in mice leads to behavioral deficits relevant to all human autism core symptoms and related neural morphofunctional abnormalities.

Wöhr M, Orduz D, Gregory P, Moreno H, Khan U, Vörckel KJ, Wolfer DP, Welzl H, Gall D, Schiffmann SN, Schwaller B.

Transl Psychiatry. 2015 Mar 10;5:e525. doi: 10.1038/tp.2015.19.

3.

Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease.

Khan UA, Liu L, Provenzano FA, Berman DE, Profaci CP, Sloan R, Mayeux R, Duff KE, Small SA.

Nat Neurosci. 2014 Feb;17(2):304-11. doi: 10.1038/nn.3606. Epub 2013 Dec 22.

4.

Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48.

Pavlopoulos E, Jones S, Kosmidis S, Close M, Kim C, Kovalerchik O, Small SA, Kandel ER.

Sci Transl Med. 2013 Aug 28;5(200):200ra115. doi: 10.1126/scitranslmed.3006373.

5.

Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver.

Schobel SA, Chaudhury NH, Khan UA, Paniagua B, Styner MA, Asllani I, Inbar BP, Corcoran CM, Lieberman JA, Moore H, Small SA.

Neuron. 2013 Apr 10;78(1):81-93. doi: 10.1016/j.neuron.2013.02.011.

6.

Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease.

Lewandowski NM, Bordelon Y, Brickman AM, Angulo S, Khan U, Muraskin J, Griffith EY, Wasserman P, Menalled L, Vonsattel JP, Marder K, Small SA, Moreno H.

Neurobiol Dis. 2013 Apr;52:84-93. doi: 10.1016/j.nbd.2012.11.014. Epub 2012 Dec 4. Erratum in: Neurobiol Dis. 2013 Jun;54:115.

7.

R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures.

Cepeda-Prado E, Popp S, Khan U, Stefanov D, Rodríguez J, Menalled LB, Dow-Edwards D, Small SA, Moreno H.

J Neurosci. 2012 May 9;32(19):6456-67. doi: 10.1523/JNEUROSCI.0388-12.2012.

8.

Monitoring early tumor response to drug therapy with diffuse optical tomography.

Flexman ML, Vlachos F, Kim HK, Sirsi SR, Huang J, Hernandez SL, Johung TB, Gander JW, Reichstein AR, Lampl BS, Wang A, Borden MA, Yamashiro DJ, Kandel JJ, Hielscher AH.

J Biomed Opt. 2012 Jan;17(1):016014. doi: 10.1117/1.JBO.17.1.016014.

9.

A pathophysiological framework of hippocampal dysfunction in ageing and disease.

Small SA, Schobel SA, Buxton RB, Witter MP, Barnes CA.

Nat Rev Neurosci. 2011 Sep 7;12(10):585-601. doi: 10.1038/nrn3085. Review.

10.

Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders.

Schobel SA, Lewandowski NM, Corcoran CM, Moore H, Brown T, Malaspina D, Small SA.

Arch Gen Psychiatry. 2009 Sep;66(9):938-46. doi: 10.1001/archgenpsychiatry.2009.115.

11.

Noninvasive and transient blood-brain barrier opening in the hippocampus of Alzheimer's double transgenic mice using focused ultrasound.

Choi JJ, Wang S, Brown TR, Small SA, Duff KE, Konofagou EE.

Ultrason Imaging. 2008 Jul;30(3):189-200.

12.

Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components.

Chen YJ, Johnson MA, Lieberman MD, Goodchild RE, Schobel S, Lewandowski N, Rosoklija G, Liu RC, Gingrich JA, Small S, Moore H, Dwork AJ, Talmage DA, Role LW.

J Neurosci. 2008 Jul 2;28(27):6872-83. doi: 10.1523/JNEUROSCI.1815-08.2008.

13.

An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus.

Pereira AC, Huddleston DE, Brickman AM, Sosunov AA, Hen R, McKhann GM, Sloan R, Gage FH, Brown TR, Small SA.

Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5638-43. Epub 2007 Mar 20.

Supplemental Content

Support Center